{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:00:19Z","timestamp":1777762819418,"version":"3.51.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/dsu.12188","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T19:59:45Z","timestamp":1362599985000},"page":"1587-1591","source":"Crossref","is-referenced-by-count":11,"title":["Analysis of Botulinum Toxin Products and Litigation in the United States"],"prefix":"10.1097","volume":"39","author":[{"given":"John B.","family":"Korman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray H.","family":"Jalian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew M.","family":"Avram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse effects reported to the US Food and Drug Administration in therapeutic and cosmetic cases.","volume":"53","author":"Cote","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R3-3-20210206","first-page":"22A","article-title":"City doctor wins 15M in Botox case. The Oklahoman.","volume":"2010","author":"Clay","year":"12","journal-title":"May"},{"key":"R5-3-20210206","first-page":"377","article-title":"Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.","volume":"12","author":"Dessy","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"R6-3-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1473-2165.2011.00593.x","article-title":"Advances in the use of botulinum neurotoxins in facial esthetics.","volume":"11","author":"Flynn","year":"2012","journal-title":"J Cosmet Dermatol"},{"key":"R7-3-20210206","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","article-title":"Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a metaanalysis of individual patient data from global clinical registration studies in 1678 participants.","volume":"61","author":"Brin","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R8-3-20210206","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","article-title":"Longterm botulinum toxin efficacy, safety, and immunogenicity.","volume":"20","author":"Mejia","year":"2005","journal-title":"Mov Disord"},{"key":"R9-3-20210206","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1524-4725.2006.32333.x","article-title":"Dosefinding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.","volume":"33","author":"Carruthers","year":"2007","journal-title":"Dermatol Surg"},{"key":"R10-3-20210206","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaad.2009.03.049","article-title":"Longterm safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: interim analysis from an openlabel extension study.","volume":"61","author":"Monheit","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R11-3-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","article-title":"Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.","volume":"67","author":"Jost","year":"2007","journal-title":"Drugs"},{"key":"R12-3-20210206","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1524-4725.2010.01706.x","article-title":"Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.","volume":"36","author":"Sattler","year":"2010","journal-title":"Dermatol Surg"},{"key":"R13-3-20210206","first-page":"28","article-title":"A phase III study of incobotulinumtoxinA in the treatment of glabellar frown lines.","volume":"4","author":"Imhof","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"R14-3-20210206","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/009885881103700202","article-title":"Offlabel drug use and promotion: balancing public health goals and commercial speech.","volume":"37","author":"Kesselheim","year":"2011","journal-title":"Am J Law Med"},{"key":"R16-3-20210206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0b013e3181f5329e","article-title":"Systemic weakness after therapeutic injections of botulinum toxin A: a case series and review of the literature.","volume":"33","author":"Crowner","year":"2010","journal-title":"Clin Neuropharm"},{"key":"R17-3-20210206","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archinternmed.2012.1416","article-title":"Outcomes of medical malpractice litigation against US physicians.","volume":"172","author":"Jena","year":"2012","journal-title":"Arch Intern Med"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1111\/dsu.12188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:08:16Z","timestamp":1620979696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201311000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1111\/dsu.12188","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}